Brickell Biotech Stock Performance
| BBI Stock | USD 0.90 0.01 1.10% |
The firm shows a Beta (market volatility) of 0.12, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Brickell Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding Brickell Biotech is expected to be smaller as well. Brickell Biotech has an expected return of -0.1%. Please make sure to confirm Brickell Biotech jensen alpha, kurtosis, price action indicator, as well as the relationship between the maximum drawdown and rate of daily change , to decide if Brickell Biotech performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Brickell Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's fundamental drivers remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders. ...more
Last Split Factor 1:45 | Dividend Date 2019-09-03 | Last Split Date 2022-07-05 |
1 | Acquisition by Hardy Reginald L of 883 shares of Brickell Biotech subject to Rule 16b-3 | 03/28/2024 |
| Begin Period Cash Flow | 30.1 M | |
| Total Cashflows From Investing Activities | -36 K |
Brickell |
Brickell Biotech Relative Risk vs. Return Landscape
If you would invest 98.00 in Brickell Biotech on January 20, 2024 and sell it today you would lose (7.00) from holding Brickell Biotech or give up 7.14% of portfolio value over 90 days. Brickell Biotech is generating negative expected returns assuming volatility of 1.9157% on return distribution over 90 days investment horizon. In other words, 16% of stocks are less volatile than Brickell, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Brickell Biotech Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Brickell Biotech's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Brickell Biotech, and traders can use it to determine the average amount a Brickell Biotech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0527
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BBI |
Estimated Market Risk
| 1.92 actual daily | 16 84% of assets are more volatile |
Expected Return
| -0.1 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Brickell Biotech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Brickell Biotech by adding Brickell Biotech to a well-diversified portfolio.
Brickell Biotech Fundamentals Growth
Brickell Stock prices reflect investors' perceptions of the future prospects and financial health of Brickell Biotech, and Brickell Biotech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Brickell Stock performance.
| Return On Equity | -1.57 | ||||
| Return On Asset | -0.8 | ||||
| Operating Margin | (6.58) % | ||||
| Current Valuation | (8.35 M) | ||||
| Shares Outstanding | 2.87 M | ||||
| Price To Earning | (35.16) X | ||||
| Price To Book | 0.41 X | ||||
| Price To Sales | 1.45 X | ||||
| Revenue | 404 K | ||||
| Gross Profit | (27.83 M) | ||||
| EBITDA | (39.38 M) | ||||
| Net Income | (39.47 M) | ||||
| Cash And Equivalents | 17.29 M | ||||
| Cash Per Share | 6.52 X | ||||
| Total Debt | 69 K | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 4.36 X | ||||
| Book Value Per Share | 5.81 X | ||||
| Cash Flow From Operations | (36.15 M) | ||||
| Earnings Per Share | (0.42) X | ||||
| Market Capitalization | 6.75 M | ||||
| Total Asset | 29.72 M | ||||
| Retained Earnings | (145.37 M) | ||||
| Working Capital | 24.79 M | ||||
| Current Asset | 52.66 M | ||||
| Current Liabilities | 5.61 M | ||||
About Brickell Biotech Performance
To evaluate Brickell Biotech Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Brickell Biotech generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Brickell Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Brickell Biotech market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Brickell's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (258.04) | (270.94) | |
| Return On Tangible Assets | (1.53) | (1.45) | |
| Return On Capital Employed | (1.82) | (1.73) | |
| Return On Assets | (1.53) | (1.45) | |
| Return On Equity | (1.83) | (1.73) |
Things to note about Brickell Biotech performance evaluation
Checking the ongoing alerts about Brickell Biotech for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Brickell Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Brickell Biotech generated a negative expected return over the last 90 days | |
| Brickell Biotech has some characteristics of a very speculative penny stock | |
| The company reported the last year's revenue of 404 K. Reported Net Loss for the year was (39.47 M) with loss before taxes, overhead, and interest of (27.83 M). | |
| Brickell Biotech has about 17.29 M in cash with (36.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.52, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Brickell Biotech has a poor financial position based on the latest SEC disclosures | |
| Latest headline from MacroaxisInsider: Acquisition by Hardy Reginald L of 883 shares of Brickell Biotech subject to Rule 16b-3 |
- Analyzing Brickell Biotech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Brickell Biotech's stock is overvalued or undervalued compared to its peers.
- Examining Brickell Biotech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Brickell Biotech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Brickell Biotech's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Brickell Biotech's stock. These opinions can provide insight into Brickell Biotech's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brickell Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more detail on how to invest in Brickell Stock please use our How to Invest in Brickell Biotech guide.Note that the Brickell Biotech information on this page should be used as a complementary analysis to other Brickell Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Complementary Tools for Brickell Stock analysis
When running Brickell Biotech's price analysis, check to measure Brickell Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brickell Biotech is operating at the current time. Most of Brickell Biotech's value examination focuses on studying past and present price action to predict the probability of Brickell Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brickell Biotech's price. Additionally, you may evaluate how the addition of Brickell Biotech to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |
Is Brickell Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brickell Biotech. If investors know Brickell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brickell Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.42) | Revenue Per Share 1.94 | Quarterly Revenue Growth 27.576 | Return On Assets (0.80) | Return On Equity (1.57) |
The market value of Brickell Biotech is measured differently than its book value, which is the value of Brickell that is recorded on the company's balance sheet. Investors also form their own opinion of Brickell Biotech's value that differs from its market value or its book value, called intrinsic value, which is Brickell Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brickell Biotech's market value can be influenced by many factors that don't directly affect Brickell Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brickell Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Brickell Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brickell Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.